Reuters logo
BRIEF-Moleculin Biotech says ‍entered into an at market issuance sales agreement with Roth Capital Partners LLC and National Securities Corp
September 15, 2017 / 9:37 PM / 2 months ago

BRIEF-Moleculin Biotech says ‍entered into an at market issuance sales agreement with Roth Capital Partners LLC and National Securities Corp

Sept 15 (Reuters) - Moleculin Biotech Inc

* Moleculin Biotech says ‍entered into an at market issuance sales agreement with Roth Capital Partners, LLC and National Securities Corp

* Moleculin Biotech says pursuant to terms of agreement, co may sell through agents shares of co's common stock of up to $13 million​ Source text: [bit.ly/2jw9Qg6] Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below